John B. Pierce Laboratory
New Haven, Connecticut, 06519, United States
NCT Number: NCT01153581
This study is designed to determine the causes of "orthostatic intolerance" which occurs more commonly in women than in men. Orthostatic tolerance is the ability to remain standing up right for long periods of time, or to avoid dizziness when moving to standing from a seated or lying position.
Looking for future studies?
Notify Me18 year–34 year
Female
Interventional
Phase 2
New Haven, Connecticut, 06519, United States
In this study we are interested in determining the impact of female reproductive hormones (estrogen and progesterone) on orthostatic tolerance (described above) so we administer these hormones to participants. We also test participants' orthostatic tolerance in our laboratory and use this information to place subjects into groups.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ganirelix acetate: .25 ml/day by subcutaneous injection
Other names: Antagon
17 beta estradiol: 0.2 mg/day (patches)
Other names: 17 beta estradiol, estradiol
progesterone, 200 mg day-1 oral
Other names: P4, Prometrium
Time frame: 2 months
We used a measure called cumulative stress index to determine orthostatic tolerance, which is the amount of time at a level of negative pressure each subject can maintain before feeling as if she is going to pass out. This is calculated by multiplying the pressure in mm Hg by the time in min.
Time frame: 2 months
This is a measure of how the body responds to changes in pressure induced by changes in position such as sitting, lying standing. The pressure changes are induced by gravity. The measurement described below to assess baroreceptor function is units of change in forearm vascular resistance for a given change in lower body negative pressure. This allows us to determine how good the body is at sending signals to the periphery to respond to postural changes.
Baroreflex sensitivity is defined as the change in interbeat interval (IBI) in milliseconds per unit change in BP. For example, when the BP rises by 10 mmHg and IBI increases by 100 ms, BRS would be 100/10 = 10 ms/mmHg.
Time frame: 2 months
Changes in blood flow in the small vessel in the skin are measured in response to sequential heat and drug stimulation. It is measured in volts, and then corrected for a maximum level and expressed as "% max." This is measured with a Laser Doppler probes, which measures volts.
Yale University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05529147
Alzheimer Disease, Autonomic Nervous System Diseases
Nijmegen, Gelderland, Netherlands
View Trial DetailsNCT06054958
Autonomic Nervous System Diseases, Chronic Fatigue Syndrome in Adolescence
Munich, Bavaria, Germany
View Trial DetailsNCT03032328
Autonomic Nervous System Diseases, Avitaminosis
Winston-Salem, North Carolina, United States
View Trial DetailsNCT03261570
Autonomic Nervous System Diseases, Nervous System Diseases
Hawthorne, New York, United States
View Trial Details